Cite
Prochetto E, Roldán C, Bontempi IA, et al. Trans-sialidase-based vaccine candidate protects against . Oncotarget. 2017;8(35):58003-58020doi: 10.18632/oncotarget.18217.
Prochetto, E., Roldán, C., Bontempi, I. A., Bertona, D., Peverengo, L., Vicco, M. H., Rodeles, L. M., Pérez, A. R., Marcipar, I. S., & Cabrera, G. (2017). Trans-sialidase-based vaccine candidate protects against . Oncotarget, 8(35), 58003-58020. https://doi.org/10.18632/oncotarget.18217
Prochetto, Estefanía, et al. "Trans-sialidase-based vaccine candidate protects against ." Oncotarget vol. 8,35 (2017): 58003-58020. doi: https://doi.org/10.18632/oncotarget.18217
Prochetto E, Roldán C, Bontempi IA, Bertona D, Peverengo L, Vicco MH, Rodeles LM, Pérez AR, Marcipar IS, Cabrera G. Trans-sialidase-based vaccine candidate protects against . Oncotarget. 2017 May 25;8(35):58003-58020. doi: 10.18632/oncotarget.18217. eCollection 2017 Aug 29. PMID: 28938533; PMCID: PMC5601629.
Copy
Download .nbib